Table 8.
Scoring of the EUL vaccine developers.
Category | Indicators | Pfizer/BioNTech | AstraZeneca–Oxford | Janssen | Moderna | Sinopharm | Sinovac |
---|---|---|---|---|---|---|---|
Research and Development | Effectiveness | 1 | 1 | ||||
Profits | 1 | 1 | |||||
Transparency and Accountability | Clinical trials | 1 | 1 | 1 | 1 | 1 | |
Vaccine Contracts | 1 | 1 | 1 | ||||
Product Delivery | COVAX % | 1 | 1 | 1 | |||
Distribution to Lower Income Countries | 1 | 1 | 1 | 1 | |||
Equitable Pricing | 1 | 1 | 1 | ||||
Intellectual Property Strategy | 1 | 1 | 1 | 1 | |||
Manufacturing Agreements | 1 | 1 | 1 | 1 | |||
Total | 4 | 6 | 5 | 4 | 5 | 6 | |
Ranking | 3 | 1 | 2 | 3 | 2 | 1 |